I don't understand where you can state that Apricus has a PIII for Femprox. Let's go over what we know about valuation of Biotechs. Biosante had one only small drug in the FDA aproval process to treat low testosterone. Yet, their market cap was upwards of $500 million because they were in PIII for libigel. If Apricus had the green light for PIII that would mean to the street, approximately 18 months for an approved drug (assuming efficacy) and our market cap would shoot up to several hundreds of millions. If it was PIII, the question would be why find a partner pre approval when a clinical at PIII would cost $10 million or less. In Fact, Pascoe was asked this question on the call:
And also in the U.S., when you were told to do trials in pre- and post-menopausal women, should we sort of understand that to mean 2 Phase III trials in each population and this is why you think it might be so large that you need a development partner?
Read his answer in the transcripts, he danced around the question and only said if room temperature was available when they start a PIII they would use it. He gave a non answer to the question. Given the FDA wants to see data for pre and post I can't see how they can start at PIII. Now, I am skeptical at PII because again, that would be a positive announcement and the path to an approved drug would be less than 3 years. I also don't see the FDA accepting a PII that is 4 years old with results out of China. So, it's either start of PI with pre and post menopause or a new PII in the same population.
That is why he needs a US partner, they have a clear path but it's a long road that requires cash and expertise.....both of which we lack right now.
As I stated before, I emailed this same question to the company and I will post the response, if I ever get it.
Let's stop the nonsense of the outright, or subtle accusations that if you are critical you are somehow a short. I am long 3 years now, underwater and want to see some value for my shares. Not management getting a nice salary, free shares for negative results!
Should I accuse the strong supporters of being Apricus employees?
AI
Market Data 
Markets 
